Arch Biotech Profile
Key Indicators
- Authorised Capital ₹ 2.50 M
as on 23-10-2024
- Paid Up Capital ₹ 1.16 M
as on 23-10-2024
- Company Age 27 Year, 3 Months
- Last Filing with ROC 31 Mar 2024
- Open Charges ₹ 11.01 Cr
as on 23-10-2024
- Satisfied Charges ₹ 18.98 Cr
as on 23-10-2024
- Revenue -4.59%
(FY 2023)
- Profit -18.73%
(FY 2023)
- Ebitda 5.77%
(FY 2023)
- Net Worth 20.66%
(FY 2023)
- Total Assets 12.59%
(FY 2023)
About Arch Biotech
The Company is engaged in the Agriculture Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2024. It's a company limited by shares with an authorized capital of Rs 2.50 M and a paid-up capital of Rs 1.16 M.
The company currently has active open charges totaling ₹11.01 Cr. The company has closed loans amounting to ₹18.98 Cr, as per Ministry of Corporate Affairs (MCA) records.
Abhijit Kashikar and Samir Kashikar serve as directors at the Company.
- CIN/LLPIN
U24200MH1997PTC110968
- Company No.
110968
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
29 Sep 1997
- Date of AGM
30 Sep 2024
- Date of Balance Sheet
31 Mar 2024
- Listing Status
Unlisted
- ROC Code
Roc Mumbai
Industry
Company Details
- Location
Nagpur, Maharashtra, India
- Telephone
- Email Address
- Website
- Social Media-
What products or services does Arch Biotech Private Limited offer?
Arch Biotech Private Limited offers a wide range of products and services, including Fertilizers and Soil Additives, Bio Fertilizers, Fertilizer.
Who are the key members and board of directors at Arch Biotech?
Board Members (2)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Abhijit Kashikar  | Whole-Time Director | 29-Sep-1997 | Current |
| Samir Kashikar | Whole-Time Director | 29-Sep-1997 | Current |
Financial Performance of Arch Biotech.
Arch Biotech Private Limited, for the financial year ended 2023, experienced Minor drop in revenue, with a 4.59% decrease. The company also saw a substantial fall in profitability, with a 18.73% decrease in profit. The company's net worth Soared by an impressive increase of 20.66%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Arch Biotech?
In 2023, Arch Biotech had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Charges (Loans)
| Lender | Amount | Status |
|---|---|---|
Others Creation Date: 29 Dec 2023 | ₹7.15 Cr | Open |
Others Creation Date: 10 Aug 2022 | ₹8.14 M | Open |
Others Creation Date: 21 Mar 2020 | ₹3.00 Cr | Open |
How Many Employees Work at Arch Biotech?
Arch Biotech has a workforce of 1 employees as of Apr 06, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Arch Biotech, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Arch Biotech's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
